Common variations in platelet glycoproteins: pharmacogenomic implications (Q28191774)

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

Europe PubMed Central

title

Common variations in platelet glycoproteins: pharmacogenomic implications (English)

0 references

1 reference

2

E J Topol

0 references

author name string

M J Quinn

series ordinal

1

0 references

language of work or name

English

0 references

publication date

November 2001

0 references

published in

Pharmacogenomics

0 references

volume

2

0 references

issue

4

0 references

page(s)

341-52

0 references

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Pharmacogenomics: a clinician's primer on emerging technologies for improved patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Territoriality in the white rhinoceros (Ceratotherium simum) Burchell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Thromboxane synthase inhibitors and receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Identification of the platelet ADP receptor targeted by antithrombotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Ticlopidine and clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Genetic and environmental contributions to platelet aggregation: the Framingham heart study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

High-throughput genotyping assay approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Platelet glycoprotein IIb. Chromosomal localization and tissue expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Platelet glycoprotein IIb/IIIa receptors and Glanzmann's thrombasthenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

The Pl(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

PlA2 polymorphism and efficacy of aspirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Systematic screening for genetic polymorphism in human platelet glycoprotein Ibalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Platelet glycoprotein Ibalpha Kozak polymorphism is associated with an increased risk of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

The human platelet alloantigens Br(a) and Brb are associated with a single amino acid polymorphism on glycoprotein Ia (integrin subunit alpha 2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Glycoprotein Ia C807T polymorphism and risk of restenosis following coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Role of P2Y1 purinoceptor in ADP-induced platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

The cell biology of thrombospondin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

A model of platelet aggregation involving multiple interactions of thrombospondin-1, fibrinogen, and GPIIbIIIa receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Platelet GPIIb-IIIa blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Glycoprotein IIIa PlA1/A2 polymorphism and sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341

Increased Platelet Aggregability Associated With Platelet GPIIIa Pl A2 Polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.2.4.341